Smriti College of Pharmaceutical Education

Require Assistant Professor/Associate Professor in Smriti College of Pharmaceutical Education

Nestled on MR 11 near flourishing bypass, Smriti College of Pharmaceutical Education (SCOPE) was founded in 1999 and is spread across 6500 sq.m of lush greens. With a humble beginning a decade ago under the aegis of “B. R. Nahata Smriti Sansthan” (BRNSS) in the memory of late Mr. B.R. Nahata – a great social leader, parliamentarian and a renowned educationalist, Smriti College of Pharmaceutical Education, Indore has carved its niche in the domain of pharmaceutical education.

Post: Associate /Assistant Professor


At least one article is seen in newspaper on obesity on daily basis; no other disease is searched (and articles are read on) as frequently as obesity. Such is the menace of obesity that even fast food giant McDonald's has put an advice in few of its offices “not to eat too much fast-food”. Obesity is defined as BMI (body mass index) 30kg\m2 or more. A person with a BMI between 25 and 29.9 are considered over weight but not obese. BMI is a simple index of weight-for-height that is commonly used to classify overweight and obesity in humans. It is also defined as a person’s weight in kilograms divided by the square of his height in meters (kg\m2). As per world health organization (WHO), BMI greater than or equal to 25 is overweight and BMI greater than or equal to 30 is obese. Obesity is a foremost health problem not only in developed nations but also in developing countries. It increases the risk of other diseases like diabetes, cardiovascular ailments, fatty liver and some forms of cancer1. Obesity is now so common in various geographies that it is beginning to replace conditions arising from malnutrition and infectious diseases as the most significant contributor to ill health. Obesity is measured using BMI and further evaluated in terms of fat distribution via the waist–hip ratio and total cardiovascular risk factors2. BMI is closely related to both percentage body fat and total body fat3. The global epidemic of obesity results from an amalgamation of such factors as genetic susceptibility, increased availability of high-energy foods and diminished need of physical activity in prevailing situation in modern society. Obesity is no more a cosmetic issue affecting certain individuals, but a pandemic threatening global well being because it exacerbates a large number of health-related problems, both independently and in association with other ailments4,5.



Amit Gangwal
Department of Pharmacognosy,
Smriti college of pharmaceutical education, Indore, Madhya Pradesh, India

Patents provide an incentive to the pharmaceutical industry to invest in the development of new medicines to treat diseases that are currently untreatable or incurable, and provide options when patients develop resistance to older drugs. Around the world it has been a challenge for last one or two decades to innovate concepts and mechanisms to hasten the drug development schemes/process, while augmenting dereplication ways in a full proof manner to save time, man power and financial input. High failure rate at any stage in drug development process is bothering and evoking various tools to be discussed like never before. The pharmaceutical industries world over, are in a period of crisis due to the poor number of approved drug molecules relative to the high levels of R&D investment. The drug industry is facing major scientific and strategic challenges. Moreover competition from generic giants is giving tough challenge to established products owing to end of patent rights. The concerns are further aggravated by couple of decisions announced by Indian courts (Nexavar® followed by long time pending battle of Gleevac®). These two decrees by Indian courts were not ruled in the favor of pharma giants; Bayer and Novartis respectively. Millions are dying in various part of world, owing to their inability to purchase the Elite Drugs, because of intellectual property rights. In this article various pros and cons have been discussed pertaining to generic medicines and patent fights of innovators world over.


Dr. Amit Gangwal,
Associate Professor,
Smriti college of pharmaceutical education, Indore

Plant remains to be the enviable source of molecules of therapeutic significance. Since antiquity, these bio resources have been in use for variety of diseases in different part of the world. Regardless of the type of plant, targeted ailment or other such parameters, the one step which is one of the most important and common is removal of the molecule or fraction or part there of from the plant biomass. Several new methods besides the usual organic solvent extraction have been developed over the last few years for the extraction of primary and secondary metabolites. These are alcohol extraction with various biocompatible solvents, recovery of carboxylic acids and antibiotics with reactive extraction, dissociation extraction, aqueous two-phase extraction, and supercritical and near critical fluid extraction. Extraction and re-extraction processes are integrated into a single step by emulsion liquid membrane and solid supported liquid membrane extractions.


About Author:
Dr. Amit Gangwal
Pharmacy college as a Lecture,
Smriti college of pharmaceutical education, Indore

The pharmaceutical industries world over, are in a period of crisis due to the poor number of approved drug molecules relative to the high levels of R&D investment. The drug industry is facing major scientific and strategic challenges. Conversion of genomics knowledge into new molecules seems to be unimpressive and futile. Moreover competition from generic giants is giving tough competitions to established products. Indian companies are no exception; rather, hardly any molecule has been delivered by Indian companies since time immemorial (readers are kindly requested to correct/update me, if I am not acknowledging some discovered molecule).